News Articles Tagged: ILK Inhibitor

Advancing Cancer Therapeutics: The Significance of ILK-IN-3 as a Pharmaceutical Intermediate

Explore the critical role of ILK-IN-3 as a pharmaceutical intermediate in the development of novel cancer therapeutics, focusing on its chemical properties and applications in drug synthesis.

The Role of Integrin-Linked Kinase (ILK) in Cancer Progression: Insights from ILK-IN-3

Explore how ILK-IN-3, a selective Integrin-Linked Kinase inhibitor, is shedding light on cancer cell migration, survival, and resistance, offering new avenues for therapeutic intervention.